Nanostructured optical photonic crystal biosensor for HIV viral load measurement

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Shafiee, Hadi ^a   Lidstone, Erich A ^b   Jahangir, Muntasir ^a   Inci, Fatih ^a   Hanhauser, Emily ^a   Henrich, Timothy J ^a   Kuritzkes, Daniel R ^a   Cunningham, Brian T ^b   Demirci, Utkan ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b University of Illinois at Urbana Champaign   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOMATERIAL;

ARTICLE; GENETIC PROCEDURES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; REPRODUCIBILITY; VALIDATION STUDY; VIRUS LOAD;

BIOSENSING TECHNIQUES; HIV-1; HUMANS; NANOSTRUCTURES; REPRODUCIBILITY OF RESULTS; VIRAL LOAD;

EID: 84897638593     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04116     Document Type: Article

References (71)

1. Robinson, W. H. et al. Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8, 295-301 (2002). (Pubitemid 34250109)
2. Wong, J., Sibani, S., Lokko, N. N., LaBaer, J. & Anderson, K. S. Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. J. Immunol. Methods 350, 171-182 (2009).
3. Ward, D. G. et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Brit. J. Cancer 94, 1898-1905 (2006). (Pubitemid 43882582)
4. Nam, M. J. et al. Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3, 2108-2115 (2003). (Pubitemid 37414076)
5. Tannapfel, A. et al. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays. J. Pathol. 201, 238-249 (2003). (Pubitemid 37258935)
6. Patz, E. F. et al. Panel of serum biomarkers for the diagnosis of lung cancer. J. Clin. Oncol. 25, 5578-5583 (2007).
7. Zhang, Z. et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 64, 5882-5890 (2004). (Pubitemid 39095590)
8. Luo, L. Y. et al. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res. 63, 807-811 (2003).
9. Diamandis, E. P. et al. Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 21, 1035-1043 (2003). (Pubitemid 46594132)
10. Diamandis, E. P. et al. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumor Biol. 24, 299-309 (2003). (Pubitemid 38327992)
11. Maurya, P., Meleady, P., Dowling, P. & Clynes, M. Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res. 27, 1247-1255 (2007). (Pubitemid 46807270)
12. Salmanzadeh, A. et al. Isolation of prostate tumor initiating cells (TICs) through their dielectrophoretic signature. Lab Chip 12, 182-189 (2012).
13. Shafiee, H., Sano, M. B., Henslee, E. A., Caldwell, J. L. & Davalos, R. V. Selective isolation of live/dead cells using contactless dielectrophoresis (cDEP). Lab Chip 10, 438-445 (2010).
14. Klevan, L., Horton, L., Carlson, D. P. & Eisenberg, A. J. Chemiluminescent detection of DNA probes in forensic analysis. Electrophoresis 16, 1553-1558 (1995).
15. Wang, S., Xu, F. & Demirci, U. Advances in developing HIV-1 viral load assays for resource-limited settings. Biotechnol. Adv. 28, 770-781 (2010).
16. Wang, S. et al. Efficient on-chip isolation of HIV subtypes. Lab Chip 12, 1508-1515 (2012).
17. Shafiee, H. et al. Acute On-Chip HIV Detection Through Label-Free Electrical Sensing of Viral Nano-Lysate. Small 9, 2553-2563 (2013).
18. Inci, F. et al. Nanoplasmonic quantitative detection of intact viruses from unprocessed whole blood. ACS Nano 7, 4733-4745 (2013).
19. Lal, S., Link, S. & Halas, N. J. Nano-Optics from Sensing to Waveguiding. Nat. Photonics 1, 8 (2007).
20. Anker, J. N. et al. Biosensing with plasmonic nanosensors. Nat. Mater. 7, 442-453 (2008). (Pubitemid 351735880)
21. Arnold, S., Khoshsima, M., Teraoka, I., Holler, S. & Vollmer, F. Shift of whispering-gallery modes in microspheres by protein adsorption. Opt. Lett. 28, 272-274 (2003).
22. Fritz, J. et al. Translating biomolecular recognition into nanomechanics. Science 288, 316-318 (2000). (Pubitemid 30226188)
23. Tasoglu, S. et al. Manipulating biological agents and cells in micro-scale volumes for applications in medicine. Chem. Soc. Rev. 42, 5788-5808 (2013).
24. Cui, Y., Wei, Q., Park, H. & Lieber, C. M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293, 1289-1292 (2001). (Pubitemid 32777412)
25. Terrel, M., Digonnet, M. J. & Fan, S. Ring-coupled Mach-Zehnder interferometer optimized for sensing. Appl. Opt. 48, 4874-4879 (2009).
26. World Health Organization, Antiretroviral therapy in low- and middle-income countries by region. Available at: http://www.who.int/hiv/topics/ treatment/data/en/ Accessed May 1 2013. (2011).
27. World Health Organization, HIV/AIDS, malaria and other diseases: HIV/AIDS indicators by country. Avilable at: http://apps.who.int/gho/data/node.main.559 Accessed May 10 2013. (2011).
28. Fiscus, S. A. et al. HIV-1 viral load assays for resource-limited settings. PLoS Med 3, e417 (2006).
29. World Health Organization, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Accessed October 10 2013. (2013).
30. Mee, P., Fielding, K. L., Charalambous, S., Churchyard, G. J. & Grant, A. D. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 22, 1971-1977 (2008).
31. van Oosterhout, J. J. G. et al. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop. Med. Int. Health 14, 856-861 (2009).
32. Vekemans, M., John, L. & Colebunders, R. When to switch for antiretroviral treatment failure in resource-limited settings? AIDS 21, 1205-1206 (2007). (Pubitemid 46763291)
33. Gale, H. B. et al. Is Frequent CD4+ T-Lymphocyte CountMonitoring Necessary for Persons With Counts ≥300 Cells/μL and HIV-1 Suppression? HIV/AIDS Brief Report 56, 4 (2013).
34. Schofield, D. J. & Dimmock, N. J. Determination of affinities of a panel of IgGs and Fabs for whole enveloped (influenza A) virions using surface plasmon resonance. J. Virol. Methods 62, 33-42 (1996). (Pubitemid 26355212)
35. Amano, Y. & Cheng, Q. Detection of influenza virus: traditional approaches and development of biosensors. Anal. Bioanal. Chem. 381, 156-164 (2005). (Pubitemid 40249212)
36. Boltovets, P. M. et al. Detection of plant viruses using a surface plasmon resonance via complexing with specific antibodies. J. Virol. Methods 121, 6 (2004).
37. Cooper, M. A. et al. Direct and sensitive detection of a human virus by rupture event scanning. Nat. Biotechnol. 19, 833-837 (2001). (Pubitemid 32816752)
38. Pineda, M. F., Chan, L. L., Kuhlenschmidt, T., Kuhlenschmidt, M. & Cunningham, B. T. rapid specific and label free detection of pocrine rotavirus using photonic crystal biosensors. IEEE Sensors 9, 8 (2009).
39. Patolsky, F. et al. Electrical detection of single viruses. Proc. Natl. Acad. Sci. U S A 101, 14017-14022 (2004). (Pubitemid 39305021)
40. Shamah, S. M. & Cunningham, B. T. Label-free cell-based assays using photonic crystal optical biosensors. Analyst 136, 12 (2011).
41. Chan, L. L., Gosangari, S. L., Watkin, K. L. & Cunningham, B. T. A label-free photonic crystal biosensor imaging method for detection of cancer cell cytotoxicity and proliferation. Apoptosis 12, 8 (2007).
42. Choi, C. J. & Cunningham, B. T. A 96-well microplate incorporating a replica molded microfluidic network integrated with photonic crystal biosensors for high throughput kinetic biomolecular interaction analysis. Lab Chip 7, 550-556 (2007). (Pubitemid 46699211)
43. Pineda, M. F. et al. Rapid Specific and Label-Free Detection of Porcine Rotavirus Using Photonic Crystal Biosensors. IEEE Sensors 9, 470-477 (2009).
44. Furin, J. J. et al. Expanding global HIV treatment: case studies from the field. Ann. N Y Acad. Sci. 1136, 12-20 (2008). (Pubitemid 351862158)
45. MH, M. The HIV-AIDS pandemic at 25 - the global response. N. Engl J. Med. 354, (2006).
46. Mamo, T. et al. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine (Lond) 5, 269-285 (2010).
47. Little, S. J., McLean, A. R., Spina, C. A., Richman, D. D. & Havlir, D. V. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 190, 841-850 (1999). (Pubitemid 29451629)
48. Rouet, F. et al. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. J. Clin. Microbiol. 43, 2709-2717 (2005). (Pubitemid 40827943)
49. Rosenberg, N. E. et al. Point-of-care Diagnostics for Acute HIV Infection: An Important Public Health Priority. J. Infect. Dis. 206, (2012).
50. Powers, K. A. et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet 378, 256-268 (2011).
51. Koopman, J. S. et al. The role of early HIV infection in the spread of HIV through populations. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14, 249-258 (1997).
52. Rosenberg, N. E. et al. Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J. Infect. Dis. 205, 528-534 (2012).
53. Laperche, S., Leballais, L., Ly, T. D. & Plantier, J. C. Failure in the Detection of HIV p24 Antigen with the Determine HIV-1/2 Ag/Ab Combo Rapid Test. J. Infect. Dis. 206, (2012).
54. Branson, B. & Stekler, J. Detection of Acute HIV Infection: We can't Close the Window. J. Infect. Dis. 205, 4 (2011).
55. Busch, M. P. et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 35, 91-97 (1995).
56. Stroock, A. D. et al. Chaotic mixer for microchannels. Science 295, 647-651 (2002). (Pubitemid 34111816)
57. Lee, W. G., Kim, Y. G., Chung, B. G., Demirci, U. & Khademhosseini, A. Nano/Microfluidics for diagnosis of infectious diseases in developing countries. Adv. Drug Deliv. Rev. 62, 449-457 (2010).
58. Nowak, M. A. et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J. Virol. 71, 7518-7525 (1997). (Pubitemid 27391692)
59. World Health Organization, The use of Antiretroviral Drugs for Treatment and Preventing HIV Infection. Available at: http://apps.who.int/iris/bitstream/ 10665/85321/1/9789241505727-eng.pdf Accessed October 2013.
60. Stevens, W. S., Scott, L. E. & Crowe, S. M. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J. Infect. Dis. 201 Suppl 1, S16-26 (2010).
61. Tanriverdi, S., Chen, L. & Chen, S. A rapid and automated sample-to-result HIV load test for near-patient application. J. Infect. Dis. 201 Suppl 1, S52-58 (2010).
62. Usdin, M., Guillerm, M. & Calmy, A. Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. J. Infect. Dis. 201 Suppl 1, S73-77 (2010).
63. Kim, Y. G., Moon, S., Kuritzkes, D. R. & Demirci, U. Quantum dot-based HIV capture and imaging in a microfluidic channel. Biosens. Bioelectron. 25, 253-258 (2009).
64. Wang, S., Inci, F., De Libero, G., Singhal, A. & Demirci, U. Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol. Adv. 31, 438-449 (2013).
65. Wang, S. et al. Portable microfluidic chip for detection of Escherichia coli in produce and blood. Int. J. Nanomed. 7, 2591-2600 (2012).
66. Moon, S. et al. Enumeration of CD4+ T-cells using a portable microchip count platform in Tanzanian HIV-infected patients. PLoS ONE 6, e21409 (2011).
67. Cunningham, B. T. et al. Label-free assays on the BIND system. J. Biomol. Screen. 9, 481-490 (2004).
68. Kirchherr, J. L. et al. High throughput functional analysis of HIV-1 env genes without cloning. J. Virol. Methods 143, 104-111 (2007). (Pubitemid 46813163)
69. Sanders-Buell, E., Salminen, M. & McCutchan, F. Sequencing Primers for HIV-1. The Human Retroviruses and AIDS 1995 Compendium: The HIV Sequence Database and Analysis Project, Available at: http://www.hiv.lanl.gov/content/ sequence/HIV/COMPENDIUM/1995/PART-III/3.pdf. Accessed October 30 2013, (1995).
70. Henrich, T. J. et al. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. J. Acquir. Immune Defic. Syndr. 55, 420-427 (2010).
71. Wang, L. et al. Nanostructured substrates for isolation of circulating tumor cells. Nano Today 8, 374-387 (2013).